-+ 0.00%
-+ 0.00%
-+ 0.00%

CERVOMED ANNOUNCES NEFLAMAPIMOD AWARDED INNOVATION PASSPORT DESIGNATION UNDER THE UK INNOVATIVE LICENSING AND ACCESS PATHWAY (ILAP) FOR TREATMENT OF DEMENTIA WITH LEWY BODIES (DLB)

Reuters·08/04/2026 09:15:00

Please log in to view news